Raymond Anderson
Vermögen: 497 486 $ am 30.06.2026
Vermögen: 497 486 $ am 30.06.2026
Raymond W.
Anderson is an Independent Director at Monopar Therapeutics, Inc. since 2017.
Former roles include Managing Director at Dow Pharmaceutical Sciences, Inc. from 2009 to 2010; Independent Director at Horizon Pharmaceutical LLC from 2012 to 2016; Chief Operating & Financial Officer at BioMarin Pharmaceutical, Inc. from 1998 to 2001; Director at Raptor Pharmaceuticals Corp.; Principal at Chiron Corp., Glycomed, Inc., Syntex Corp., and Fusion Medical Technologies, Inc.; Chief Financial Officer at ProRhythm, Inc.; and Finance Manager at Memorex Corp.
Education includes an MBA from Harvard University, graduate studies at George Washington University, and undergraduate studies at the US Military Academy.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MONOPAR THERAPEUTICS INC 0,08 % | 31.03.2026 | 5.373 ( 0,08 % ) | 497 486 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.04.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Direktor/Vorstandsmitglied | 25.10.2016 |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes topical drug products | Finanzdirektor/CFO | 01.01.2009 |
| BIOMARIN PHARMACEUTICAL INC. | Finanzdirektor/CFO | 01.01.2001 |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Provides information technology solutions | Corporate Officer/Principal | - |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 14 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Glycomed, Inc.
Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals based on complex carbohydrates | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Fusion Medical Technologies, Inc.
Fusion Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops surgical sealants for the treatment of surgical wounds | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ProRhythm, Inc.
ProRhythm, Inc. Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes topical drug products | Health Technology |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Provides information technology solutions | Technology Services |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen